Speaker: Greg Charville
At the end of the session, participants will be able to:
1. identify challenges and pitfalls in applying immunohistochemical assays to the diagnosis of bone tumors.
2. explore opportunities for using novel molecularly targeted immunohistochemical tools in the diagnostic classification of bone tumors.
3. appreciate the continued importance of histomorphology and imaging in the assessment of bone tumors.